Cancer is the second leading cause of death in the United States, with an estimated 1,762,450 new cases diagnosed and 606,880 deaths in 2019 alone. While important advances have been made in the development of treatments for cancer, including surgery, a number of challenges remain. Not least: sur...
Search Results: Cancer
Crowds Cure Cancer at RSNA 2017
Can crowdsourcing provide us with a cure for cancer? We hope to find out. Join us in an experiment at the RSNA annual meeting next week, where just a few minutes of your time could move us closer to this ever-elusive goal. Advances in artificial intelligence and machine learning have broad pot...
All in a Day’s Work: Veronica Clavijo Jordan on tackling cancer and crowdfunding molecular imaging research
As a child in La Paz, Bolivia, Veronica Clavijo Jordan was intrigued by science and medicine. “I used to love astronomy and biology,” she says. “I particularly remember loving the biology classes where we had lab and learned about anatomy.” Today, as an instructor in the MGH Martinos Center in Ch...
Metabolomic Information Highly Useful for Predicting Future Prostate Cancer
Early-Stage Lung Cancer May Be Detected from a Drop of Blood
Emery N. Brown Wins 2018 Dickson Prize in Science for Cancer Research
Carnegie Mellon University announced Dec. 5 that Emery N. Brown, the Warren M. Zapol Professor of Anaesthesia at Harvard Medical School and anesthesiologist at Massachusetts General Hospital, the Associate Director of the Institute for Medical Engineering and Science, the Edward Hood Taplin Profe...
PET/MRI Superior to MRI Alone for Staging of Rectal Cancer
Thomas Deisboeck
Tom Deisboeck has spent over 25 years in life sciences research. He holds an MD (Dr. med) from the Technical University of Munich as well as an MBA from Massachusetts Institute of Technology (MIT). Dr. Deisboeck is an Associate Professor of Radiology (PT) at Massachusetts General Hospital and Har...
Albert Kim
I am a medical oncologist with interests in using machine learning and Omics to develop precision-based treatment paradigms for cancer patients. I have a special interest in central nervous system metastases, and my laboratory efforts leverage Omics-based techniques, medical imaging, and machine ...
Anand Kumar
Dr. Kumar's research is focused on development and translation of novel biomedical optical techniques for preclinical and clinical applications. He has more than 15 years of experience in theory, modeling and experimental aspects of biological optical imaging. Over the past decade, his group has ...
Zdravka Medarova
Zdravka Medarova, PhD, is an Associate Professor of Radiology at Harvard Medical School. She is a geneticist/cancer biologist by training and has an extensive background in molecular biology, genetics, and tumor biology and therapy. The focus of her research has been the development and testing o...
Yi-Fen Yen
Over the past two decades, Dr. Yen has devoted herself to the development of advanced MRI techniques, for hyperpolarized metabolic imaging, cancer imaging and functional imaging in clinical and pre-clinical research. She is an MR physicist with >100 publications in peer-reviewed scientific jou...
Byung Hee Yoo
Dr. Byung Hee Yoo's expertise lies in “theranostic cancer imaging." His research has focused on quantitative visualization of biological/physiological events. Since reporting the first peptidyl MR contrast agents, he has developed a wide spectrum of additional imaging probes for the quantitation ...
Hyperpolarized Carbon-13 Imaging Is Coming to the Martinos Center
The MGH Martinos Center for Biomedical Imaging has received NIH funding to purchase a carbon-13 polarizer for translational and clinical metabolic imaging research. The instrument will be part of a new initiative in Hyperpolarized Imaging Program directed by Yi-Fen Yen, assistant professor of rad...
Stefan Carp
Dr. Carp's research group focuses on the development and clinical translation of light-based non-invasive sensing and imaging methods for disease detection and management. Major thrusts include the use of near-infrared spectroscopy and tomography as well as diffuse correlation spectroscopy to adv...
Dania Daye
Dania Daye, MD, PhD is an Assistant Professor of Radiology at Massachusetts General Hospital (MGH) and Harvard Medical School. She is the co-director of IR Research at MGH and Director of the Precision Interventional and Medical Imaging (PIMI) Research Group. Her research centers around the appli...
Nanodiamond-enhanced MRI: A Dazzling New Approach to Imaging
Nanodiamonds – synthetic industrial diamonds only a few nanometers in size – have recently attracted considerable attention because of the potential they offer for the targeted delivery of vaccines and cancer drugs as well as for other uses. Thus far, options for imaging nanodiamonds have been li...
Bin Deng
Bin Deng, PhD, is a biomedical scientist whose research interests revolve around near-infrared (NIR) spectroscopy, functional optical imaging, the interactions between NIR light and tissue, noninvasive optical biomarkers and the pathophysiology of diseases. Dr. Deng investigates the intersection ...
Veronica Clavijo Jordan
Dr. Clavijo Jordan's interests include the use of molecular MR imaging to detect and characterize inflammation, fibrosis and cancer. She is particularly interested in understanding the role metals play in the development of disease. Recently, she and colleagues have been using molecular MRI probe...
The Past, Present and Future of Molecular Imaging @ Martinos
Over the past several months, the MGH Martinos Center has been both celebrating the past and looking toward the future of its molecular imaging effort – with a symposium held last fall and now a series of initiatives designed to bolster the molecular imaging community. While there has always b...